Catch of the Day: New Serum Amyloid A (SAA) Antibody Is a Valuable Tool to Study Fish Health in Salmonids

Cells. 2023 Aug 19;12(16):2097. doi: 10.3390/cells12162097.

Abstract

Serum amyloid A (SAA) proteins belong to a family of acute-phase reactants, playing an integral role in defending the organism from pathological damage. Despite a wealth of data on the regulation of SAA transcripts in teleosts, there is only limited information on these proteins' abundance in fish. The aim of this study is to characterise SAA protein levels in salmonids using a newly developed antibody specific to salmonid SAA. The salmonid SAA antibody detected SAA and accurately discriminated between stimulated and control specimens from rainbow trout macrophage cell line (RTS-11) in vitro, as well as rainbow trout challenged with Aeromonas salmonicida- or flagellin-stimulated Atlantic salmon in vivo. The presence of SAA protein was analysed in RTS-11 cell line supernatants, liver, and spleen samples using ELISA, immunoblotting, and immunohistochemistry. This study is the first to characterise SAA protein levels in salmonids in vivo and in vitro. The newly developed salmonid SAA antibody was able to discriminate between stimulated and unstimulated specimens, showing that it can be used to study the acute-phase response in salmonids with the potential to be further developed into assays to monitor and evaluate health in wild and farmed fish.

Keywords: RTS-11 cell line; SAA antibody; SAA recombinant protein; fish health; research tools; salmonids; serum amyloid A (SAA).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute-Phase Proteins
  • Animals
  • Antibodies
  • Enzyme-Linked Immunosorbent Assay
  • Oncorhynchus mykiss*
  • Serum Amyloid A Protein*

Substances

  • Serum Amyloid A Protein
  • Antibodies
  • Acute-Phase Proteins

Grants and funding

This work was funded by the United Kingdom Research and Innovation (UKRI) through the Innovate UK programme: Knowledge Transfer Partnerships (KTP) (partnership No. KTP12327) and Vertebrate Antibodies Ltd. (VAL).